These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 17344302)
1. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. Critchfield JW; Lemongello D; Walker DH; Garcia JC; Asmuth DM; Pollard RB; Shacklett BL J Virol; 2007 Jun; 81(11):5460-71. PubMed ID: 17344302 [TBL] [Abstract][Full Text] [Related]
2. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782 [TBL] [Abstract][Full Text] [Related]
3. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079 [TBL] [Abstract][Full Text] [Related]
4. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects. Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505 [TBL] [Abstract][Full Text] [Related]
5. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003 [TBL] [Abstract][Full Text] [Related]
6. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094 [TBL] [Abstract][Full Text] [Related]
7. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093 [TBL] [Abstract][Full Text] [Related]
8. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554 [TBL] [Abstract][Full Text] [Related]
9. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. Edwards BH; Bansal A; Sabbaj S; Bakari J; Mulligan MJ; Goepfert PA J Virol; 2002 Mar; 76(5):2298-305. PubMed ID: 11836408 [TBL] [Abstract][Full Text] [Related]
10. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients. López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614 [TBL] [Abstract][Full Text] [Related]
11. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag. Peters C; Peng X; Douven D; Pan ZK; Paterson Y J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365 [TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290 [TBL] [Abstract][Full Text] [Related]
13. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073 [TBL] [Abstract][Full Text] [Related]
14. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells. López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792 [TBL] [Abstract][Full Text] [Related]
15. Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection. Ibarrondo FJ; Anton PA; Fuerst M; Ng HL; Wong JT; Matud J; Elliott J; Shih R; Hausner MA; Price C; Hultin LE; Hultin PM; Jamieson BD; Yang OO J Virol; 2005 Apr; 79(7):4289-97. PubMed ID: 15767429 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902 [TBL] [Abstract][Full Text] [Related]
17. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses. Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653 [TBL] [Abstract][Full Text] [Related]
18. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection. Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052 [TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis. de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510 [TBL] [Abstract][Full Text] [Related]
20. Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen. Peut V; Kent SJ J Virol; 2007 Dec; 81(23):13125-34. PubMed ID: 17898063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]